Clinical Trials
2 trialsNCT05012371 2026-03-05
Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT01715935 2016-08-19
NEORAD
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
Phase 2 Completed